Publication Topic

Covington TR, Barton HA, Clewell HJ III. Evaluating pharmacokinetics and pharmacodynamics for noncancer effects from trichloroethylene (TCE). Poster presented at the Society of Toxicology Annual Meeting, Cincinnati, OH, March 1997.

Sauers L and Perry C. 1996. Regulatory affairs – A growing opportunity for toxicologists. SOT Communiqué, May/June 1996.

Choksi NY, Kodavanti PRS, Tilson H, Booth RG. 1996. Effects of polychlorinated biphenyls on brain tyrosine hydroxylase activity in rats. Fundam Appl Toxicol 39:76–80, DOI: 10.1006/faat.1997.2351.

Hochberg F, Miller G, Valenzuela R, McNelis S, Crump KS, Covington T, Valdivia G, Hochberg B, Trustman JW. 1996. Late motor deficits of Chilean manganese miners: A blinded control study. Neurology 47:788–795.

Allen BC, Covington TR, Clewell HJ III. 1996. Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform. Toxicology 111:289–303.

Choksi NY, Hussain A, Booth RG. 1996. 2-Phenylaminoadenosine stimulates adenylyl cyclase activity and dopamine biosynthesis through an A2 receptor mediated mechanism. Brain Res 761:151–155, DOI: 10.1016/s0006-8993(97)00445-9.

Choksi NY, Wyrick SD, Booth RG. Modulation of brain dopamine synthesis in vivo by a putative σ 3 agonist via a G-protein coupled receptor mechanism. Poster presented at Society for Neuroscience Annual Meeting, 1996

Lea IA, Richardson RT, Widgren EE, O’Rand MG. 1996. Cloning and sequencing of cDNAs encoding the human sperm protein, Sp17. Biochim Biophys Acta 1307(3):263–266.

Covington TR, Clewell HJ III, Gearhart JM, Andersen ME. Developing physiologically-based pharmacokinetic (PB-PK) models for manganese and iron. Poster presented at the Society of Toxicology Annual Meeting, Anaheim, CA, March 1996.

Choksi NY, Waller CL, Booth RG. Neurotoxic and neuroprotective effects of polychlorinated biphenyls and adenosine compounds in rat brain. Presented at Society for Neuroscience Annual Meeting, San Diego, CA, November 1995.

Norton JN, Rylander LA, Richards JL. 1995. In vitro oral mucosa irritation testing with human cell cultures. Toxicol In Vitro 9(1):67–74.

Vater ST, Velazquez SF, Cogliano VJ. 1995. A case study of cancer data set combinations for PCBs. Regul Toxicol Pharmacol 22:2–10.

Prioleau C, Montague DM, Choksi NY, Southerland SB, Lawler CP, Mailman RB. Unusual neurochemical properties of the novel antipsychotic OPC-14597 in rat striatum. Poster presented at Society for Neuroscience Annual Meeting, 1995.

Covington TR, Gearhart JM, Clewell HJ. A physiologically based pharmacokinetic (PBPK) model for 133Xe and 222Rn in the human. Poster presented at the Society of Toxicology Annual Meeting, Baltimore, MD, March 1995.

Gargas M, Norton R, Harris MA, Paustenbach D, Finley B. 1994. Urinary excretion of chromium following ingestion of chromite ore processing residue in humans: Implications for biomonitoring. Risk Anal 14(6):1019-1024.

Choksi NY, Hussain A, Owens CE, Myers AM, Harvey RD, Baldessarini RJ, Wyrick SD, Booth RG. Adenosine A2 and PAT- σ3 agonists affect adenylyl cyclase activity and dopamine synthesis. Poster presented at North Carolina Society for Neuroscience Meeting, 1994.

Choksi NY, Hussain A, Myers AM, Owens CE, Harvey RD, Wyrick SD, Baldessarini RJ, Booth RG. Stimulation of brain cAMP and dopamine synthesis by adenosine A2 and σ3 agonists. Poster presented at Society for Neuroscience Annual Meeting, 1994

Haws, L. Principles of toxicology and risk assessment. Presented at the University of Texas at Austin LBJ School of Public Affairs, Austin, TX, September 1993.

Vater ST, McGinnis PM, Schoeny RS, Velazquez SF. 1993. Biological considerations for combining carcinogenicity data for quantitative risk assessment. Regul Toxicol Pharmacol 18(3):403–418.

Vater ST, Hollingsworth L, Baldwin DM, Warshawsky D. 1991. Comparative metabolism of 7,12-dimethylbenz[a]anthracene by the perfused liver and liver microsomal preparations from Sprague-Dawley rats. Carcinogenesis 12(12):2379–2382.